CEPI FA2 Preclinical Development Award
Funds organizations conducting preclinical vaccine development for CEPI priority pathogens and Disease X exemplars through CEPI's Innovations call.
CEPI (Coalition for Epidemic Preparedness Innovations), a non-profit international association headquartered in Oslo, administers this grant under its Innovations to Prepare for Future Epidemics and Pandemics call — specifically Focus Area 2, which targets vaccine candidates for priority pathogens and viral families. Awards of up to US $5 million fund preclinical proof-of-concept work, including I…
Preclinical development of vaccine candidates for Lassa Fever and Disease X exemplar viruses (paramyxoviruses, arenaviruses, coronaviruses, phenuiviruses, nairoviruses). Covers IND-enabling studies, CMC development, analytical methods, process optimization, scale-up, formulation, and preclinical efficacy studies.
Sign up free to see the funding breakdown
Sign up free to see the industries in scope
Sign up free to see the full eligibility
Sign up free to see how to apply
Sign up free to see what you submit
Sign up free to see the timeline
Sign up free to see where teams trip up